7 tips to cut your prescription costs

Comment icon 0 Comments
Last year the U.S. sustained the biggest increase in prescription drug spending since 2003, according to a report published this spring by... Read more

Pharma stiffs suppliers on invoice payment times: accounting or crime?

Comment icon 0 Comments
Any supplier of services to the pharmaceutical industry is acutely aware that the drug companies now take far longer to pay invoices. In many... Read more

Pharma distorts the facts to keep Medicare from negotiating drug prices

Comment icon 0 Comments
In 1967, Richard S. Harris wrote a four-part series for The New Yorker, describing how Medicare came to be enacted. The leading opponent of... Read more

Pharma Weakens FDA Oversight as the Price of Letting Congress Increase NIH Funding

Comment icon 0 Comments
Last Friday, July 10, the United States House of Representatives passed H.R. 6 by a vote of 344-77. Pennsylvania Congressmen Barletta, Boyle... Read more

Pharma's specialty drug pricing can torpedo US health care

Comment icon 0 Comments
This past February CVS/Caremark issued a report that forecast a new class of cholesterol drugs, the PCSK-9’s, will cost the U.S. health... Read more

Why pharma can't adapt to the changing health environment

Comment icon 0 Comments
In nearly every sector of health care, competing companies are acting aggressively to position themselves for prospering in a rapidly changing... Read more

Trans-Pacific Partnership: Pharma's payoff for Obamacare neutrality

Comment icon 0 Comments
In 1993 the new Clinton administration decided to make health care reform the signature issue of its first term. Bill Clinton appointed his... Read more

Health insurers balance long- and short-term moves but can pharma?

Comment icon 0 Comments
Commercial success for a new drug brand increasingly depends on whether and, how much, third-party payers will reimburse for it. As more physicians... Read more